热带酰胺
散瞳
苯肾上腺素
医学
环孢素
早产儿视网膜病变
麻醉
血压
眼科
小学生
心率
内科学
胎龄
怀孕
遗传学
神经科学
生物
作者
Boo-Kian Khoo,Adrian Koh,P Cheong,Nai-Kiong Ho
标识
DOI:10.3928/0191-3913-20000101-05
摘要
ABSTRACT Purpose: This study examined whether safe and effective mydriasis can be achieved in premature infants with heavily pigmented irides using combination cyclopentolate 0.2% and phenylephrine 1% eyedrops. Methods: A prospective, randomized double-blind study was performed to compare combination cyclopentolate 0.2% and phenylephrine 1% eyedrops with triple instillation of tropicamide 0.5% and phenylephrine 2.5%. Twenty-eight consecutive babies with dark irides and birthweight <1600 g referred for screening for retinopathy of prematurity comprised the study population. Infants' eyes were randomly dilated twice with both regimens within a 2-week period. Blood pressure, heart rate, and pupil size were measured. Results: Good mydriasis was achieved in both groups with no significant differences in pupil size or blood pressure (systolic, diastolic, or mean arterial pressures) over starting baseline values. Pulse rates decelerated below the baseline values in both groups, but these differences were not large. Conclusion: The single combination eyedrop of cyclopentolate 0.2% and phenylephrine 1% is as effective and safe a mydriatic for infants with dark irides as both tropicamide 0.5% and phenylephrine 2.5%. Journal of Pediatric Ophthalmology and Strabismus 2000;37:15-20.
科研通智能强力驱动
Strongly Powered by AbleSci AI